Remmel H. Lawrence
SEC CIK 1551817 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ATOS | ATOSSA THERAPEUTICS, INC. | Dir | 10.7K | $7,000 | — | 2 | 2025-03-26 | 2026-05-12 |
Most active insiders at ATOS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Daniel Mark James | CFO | — | — |
| 2 | Cigler Tessa | Dir | — | — |
| 3 | Finn Jonathan | Dir | — | — |
| 4 | Chen Shu-Chih | Dir | — | — |
| 5 | Galli Stephen J | Dir | — | — |
| 6 | Remmel H. Lawrence | Dir | — | — |
| 7 | Steinhart Richard I | Dir | — | — |
| 8 | QUAY STEVEN C | Pres, CEO, Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-14 16:26 | 2026-05-12 | ATOS | ATOSSA THERAPEUTICS, INC. | Remmel H. Lawrence | Dir | A - Grant | $0.00 | +10.0K | 10.7K | +1,464% | $0 | |
| 2025-03-28 | 2025-03-26 | ATOS | ATOSSA THERAPEUTICS, INC. | Remmel H. Lawrence | Dir | P - Purchase | $0.7 | +10.0K | 10.3K | +3,891% | +$7,000 |
Purchase Sale Sale after option exercise All abbreviations